Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-08

Clinical Trial Update: DILIN - Prospective Study

View source ↗

Summary

A prospective DILI study run by the Drug-Induced Liver Injury Network (DILIN), sponsored by Duke University, is currently in recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Duke University | Conditions: Liver Diseases | Status: RECRUITING